Merck
MRK
#64
Rank
โ‚ฌ207.95 B
Marketcap
83,26ย โ‚ฌ
Share price
-2.06%
Change (1 day)
-13.05%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): 6,77ย โ‚ฌ

According to Merck's latest financial reports the company's current EPS (TTM) is 6,53ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of 5,81ย โ‚ฌ an increase over its 2023 EPS that were of 0,13ย โ‚ฌ.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)6,77ย โ‚ฌ16.58%
20245,81ย โ‚ฌ4308.46%
20230,13ย โ‚ฌ-97.32%
20224,92ย โ‚ฌ10.92%
20214,44ย โ‚ฌ84.68%
20202,40ย โ‚ฌ-27.2%
20193,30ย โ‚ฌ63.44%
20182,02ย โ‚ฌ151.11%
20170,80ย โ‚ฌ-54.58%
20161,77ย โ‚ฌ30.21%
20151,36ย โ‚ฌ-61.99%
20143,58ย โ‚ฌ180.51%
20131,28ย โ‚ฌ-31.82%
20121,87ย โ‚ฌ6.62%
20111,75ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,48ย โ‚ฌ-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,97ย โ‚ฌ 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
17,63ย โ‚ฌ 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,55ย โ‚ฌ-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
3,18ย โ‚ฌ-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
3,09ย โ‚ฌ-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
6,32ย โ‚ฌ-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
6,92ย โ‚ฌ 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
11,20ย โ‚ฌ 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA